Home › Funds › Keenan, LLC › INSM
Keenan, LLC position in INSM
INSMED INC · Health Care
Keenan, LLC reported holding 2,121 shares of INSM (INSMED INC) in its Q3 2026 13F filing — a position valued at US$242K, representing 0.17% of its reported portfolio and ranking #40 among its reported holdings. Keenan, LLC has disclosed INSM holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-10-23 · Source: SEC EDGAR Form 13F-HR
How Keenan, LLC's INSM position evolved
Keenan, LLC first disclosed a stake in INSM in Q4 2025 at 2,121 shares (US$369K). Across 4 filings, Keenan, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 2,121 shares valued at US$242K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 2.12K | $369.14K | New |
| Q1 2026 | 2.12K | $346.83K | Hold |
| Q2 2026 | 2.12K | $226.14K | Hold |
| Q3 2026 | 2.12K | $242.09K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About INSM and 13F data
INSM (INSMED INC) is a Health Care company. 40 other funds we track also report a position in INSM — the largest reported positions include BAKER BROS. ADVISORS LP (US$937.8M), Darwin Global Management, Ltd. (US$673.6M), Orbis Allan Gray Ltd (US$647.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding INSM
- BAKER BROS. ADVISORS LP 8.80M sh · $937.84M · Q2 2026
- Darwin Global Management, Ltd. 6.43M sh · $673.60M · Q2 2026
- Orbis Allan Gray Ltd 6.08M sh · $647.88M · Q2 2026
- D. E. Shaw & Co 5.94M sh · $633.12M · Q2 2026
- Artisan Partners Limited Partnership 5.44M sh · $580.20M · Q2 2026
- RTW INVESTMENTS, LP 4.84M sh · $516.35M · Q2 2026
- Maverick Capital 2.15M sh · $229.31M · Q2 2026
- MAVERICK CAPITAL LTD 2.15M sh · $229.31M · Q2 2026
- Qube Research & Technologies Ltd 1.68M sh · $179.37M · Q2 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 1.63M sh · $173.74M · Q2 2026
- Integral Health Asset Management, LLC 1.60M sh · $170.59M · Q2 2026
- Bellevue Group AG 1.39M sh · $148.57M · Q2 2026
More on Keenan, LLC
FAQ
How long has Keenan, LLC held INSM?
Keenan, LLC has disclosed INSM holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Keenan, LLC's current position in INSM?
As of Q3 2026, Keenan, LLC holds 2.12K shares of INSM (INSMED INC), valued at $242.09K, representing 0.17% of its reported portfolio and ranking #40.
Has Keenan, LLC been buying or selling INSM?
In the latest 13F filing (Q3 2026), Keenan, LLC held unchanged its position in INSM.
Which other funds hold INSM?
Other major institutional holders of INSM include BAKER BROS. ADVISORS LP, Darwin Global Management, Ltd., Orbis Allan Gray Ltd, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.